Opinion · 2016
OtherPublished 13 Jul 2016
When should the sequential parallel comparison design be used in clinical trials?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Randomized clinical trials in many conditions such as mental illness, pain, addiction, allergy and asthma are subject to moderate-to-high rates of placebo response. This reduces the effect size for the comparison of the active treatment to the placebo group, hence reducing the efficiency of studies. Since attempts to resolve this problem using a placebo lead-in design have not been successful, in 2003 the sequential parallel comparison design (SPCD) was developed. In the SPCD, the study is conducted in two treatment stages, with the efficacy analysis including (a) all subjects in stage 1 and (b) stage 2 data from stage 1 placebo nonresponders. The relevant data from the two stages are pooled to compute an overall p-value. This article reviews the situations in which the SPCD is preferable to the standard parallel design as well as the circumstances in which SPCD is not a good choice.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 20 Jan 2017
Comparison of crestal bone loss and radiographic bone density change around immediate functional versus non-functional loaded dental implants: A parallel group randomized clinical trial
Conference abstract · 18 Jan 2019
The effect of auriculotherapy on stress, anxiety, and depression in MS patients: A double blind randomized clinical control trial (parallel design)
Research article · 2021
Cabergoline Versus Dydrogesterone In Infertile Women With Endometriosis: A Parallel-Design Randomized Clinical Trial
Conference abstract · 12 Mar 2018
Effect of auriculotherapy on multiple sclerosis related pain: a double blind randomized clinical control trial parallel design
More from this journal
The newest in Clinical Investigation.
Article · 30 Apr 2025
Vaccine Clinical Trials: Ensuring Safety, Immunity, and Public Health Protection
Article · 30 Apr 2025
Safety and Toxicity Assessment in Clinical Research: Ensuring Patient Protection and Drug Reliability
Article · 30 Apr 2025
Regulatory Compliance (FDA, EMA, CDSCO) in Drug Efficacy Studies: Ensuring Global Standards in Clinical Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Investigation
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Lee Baer”
- BylineArticles whose byline prints “Anastasia Ivanova”
